19.6800.41% ( +0.080 )
Delay Closed: Nov 12, 16:08:00Valuation
Current ValuationThe current P/E ratio is 14.34, within the reasonable range, cheaper than 52.11% of the time in the past 1 years, and the industry ranks 4/15, the industry Median 13.41.
14.34xP/E
HK$19.68Stock price
HK$1.37Earnings per share
14.34xP/E
Stock priceHK$19.68Earnings per shareHK$1.37
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 14.44x
- Typical range
- 13.03x–32.11x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 13.41x
013263952
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 13.41x
0x10x20x30x40x50x
| Name/Symbol | |||
|---|---|---|---|
06127HKJOINN | 13.69x | 255.81% | HK$18.28B |
03880HKMedtide Inc. | 14.34x | -- | HK$2.79B |
01873HKVIVA BIOTECH | 13.28x | -- | HK$2.72B |
06118HKAUSTAR | 13.41x | -- | HK$266.54M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
